Selected research
Market Structure
Global Exosome Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Exosome Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Exosome Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Exosome Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Exosome Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Exosome Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Exosome Service include LipExoGen Biotech, Creative Biostructure, Immunostep Biotech, AMSBIO, Frontage Labs, EVerZom, System Biosicences (SBI), Exosome Diagnostics and Creative Bioarray, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Exosome Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Exosome Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Exosome Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Exosome Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Exosome Service Segment by Company
LipExoGen Biotech
Creative Biostructure
Immunostep Biotech
AMSBIO
Frontage Labs
EVerZom
System Biosicences (SBI)
Exosome Diagnostics
Creative Bioarray
Exosomics
Creative Proteomics
RoosterBio
Clara Biotech
Luminous BioSciences
Capital Biosciences
Anazao
Alpha Nano Tech
NCELL
Wayen Biotechnologies (Shanghai)
Shanghai Yanjiang Biotechnology
Exosome Service Segment by Type
Exosome Isolation
Exosome Identification
Exosome Analysis
Other
Exosome Service Segment by Application
Medicine
Biological
Other
Exosome Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exosome Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Exosome Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Exosome Service industry.
Chapter 3: Detailed analysis of Exosome Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Exosome Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Exosome Isolation
- Exosome Identification
- Exosome Analysis
- Other
Applications
- Medicine
- Biological
- Other
Companies covered
- LipExoGen Biotech
- Creative Biostructure
- Immunostep Biotech
- AMSBIO
- Frontage Labs
- EVerZom
- System Biosicences (SBI)
- Exosome Diagnostics
- Creative Bioarray
- Exosomics
- Creative Proteomics
- RoosterBio
- Clara Biotech
- Luminous BioSciences
- Capital Biosciences
- Anazao
- Alpha Nano Tech
- NCELL
- Wayen Biotechnologies (Shanghai)
- Shanghai Yanjiang Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Exosome Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Exosome Isolation
- 1.2.3 Exosome Identification
- 1.2.4 Exosome Analysis
- 1.2.5 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Exosome Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Medicine
- 1.3.3 Biological
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Exosome Service Growth Trends by Region
- 1.5.1 Global Exosome Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Exosome Service Market Size by Region (2021-2026)
- 1.5.3 Exosome Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Exosome Service Market Dynamics
- 2.1 Exosome Service Industry Trends
- 2.2 Exosome Service Industry Drivers
- 2.3 Exosome Service Industry Opportunities and Challenges
- 2.4 Exosome Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Exosome Service Revenue by Company (2021-2026)
- 3.2 Global Exosome Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Exosome Service Key Company Head office and Area Served
- 3.4 Global Exosome Service Company, Product Type & Application
- 3.5 Global Exosome Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Exosome Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Exosome Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Exosome Service Tier 1, Tier 2, and Tier 3
4 Exosome Service Market by Type
- 4.1 Global Exosome Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Exosome Service Market Size by Type (2021-2032)
- 4.3 Global Exosome Service Market Size Share by Type (2021-2032)
5 Exosome Service Market by Application
- 5.1 Global Exosome Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Exosome Service Market Size by Application (2021-2032)
- 5.3 Global Exosome Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 LipExoGen Biotech
- 6.1.1 LipExoGen Biotech Company Information
- 6.1.2 LipExoGen Biotech Business Overview
- 6.1.3 LipExoGen Biotech Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 LipExoGen Biotech Exosome Service Product Portfolio
- 6.1.5 LipExoGen Biotech Recent Developments
- 6.2 Creative Biostructure
- 6.2.1 Creative Biostructure Company Information
- 6.2.2 Creative Biostructure Business Overview
- 6.2.3 Creative Biostructure Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Creative Biostructure Exosome Service Product Portfolio
- 6.2.5 Creative Biostructure Recent Developments
- 6.3 Immunostep Biotech
- 6.3.1 Immunostep Biotech Company Information
- 6.3.2 Immunostep Biotech Business Overview
- 6.3.3 Immunostep Biotech Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Immunostep Biotech Exosome Service Product Portfolio
- 6.3.5 Immunostep Biotech Recent Developments
- 6.4 AMSBIO
- 6.4.1 AMSBIO Company Information
- 6.4.2 AMSBIO Business Overview
- 6.4.3 AMSBIO Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 AMSBIO Exosome Service Product Portfolio
- 6.4.5 AMSBIO Recent Developments
- 6.5 Frontage Labs
- 6.5.1 Frontage Labs Company Information
- 6.5.2 Frontage Labs Business Overview
- 6.5.3 Frontage Labs Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Frontage Labs Exosome Service Product Portfolio
- 6.5.5 Frontage Labs Recent Developments
- 6.6 EVerZom
- 6.6.1 EVerZom Company Information
- 6.6.2 EVerZom Business Overview
- 6.6.3 EVerZom Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 EVerZom Exosome Service Product Portfolio
- 6.6.5 EVerZom Recent Developments
- 6.7 System Biosicences (SBI)
- 6.7.1 System Biosicences (SBI) Company Information
- 6.7.2 System Biosicences (SBI) Business Overview
- 6.7.3 System Biosicences (SBI) Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 System Biosicences (SBI) Exosome Service Product Portfolio
- 6.7.5 System Biosicences (SBI) Recent Developments
- 6.8 Exosome Diagnostics
- 6.8.1 Exosome Diagnostics Company Information
- 6.8.2 Exosome Diagnostics Business Overview
- 6.8.3 Exosome Diagnostics Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Exosome Diagnostics Exosome Service Product Portfolio
- 6.8.5 Exosome Diagnostics Recent Developments
- 6.9 Creative Bioarray
- 6.9.1 Creative Bioarray Company Information
- 6.9.2 Creative Bioarray Business Overview
- 6.9.3 Creative Bioarray Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Creative Bioarray Exosome Service Product Portfolio
- 6.9.5 Creative Bioarray Recent Developments
- 6.10 Exosomics
- 6.10.1 Exosomics Company Information
- 6.10.2 Exosomics Business Overview
- 6.10.3 Exosomics Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Exosomics Exosome Service Product Portfolio
- 6.10.5 Exosomics Recent Developments
- 6.11 Creative Proteomics
- 6.11.1 Creative Proteomics Company Information
- 6.11.2 Creative Proteomics Business Overview
- 6.11.3 Creative Proteomics Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Creative Proteomics Exosome Service Product Portfolio
- 6.11.5 Creative Proteomics Recent Developments
- 6.12 RoosterBio
- 6.12.1 RoosterBio Company Information
- 6.12.2 RoosterBio Business Overview
- 6.12.3 RoosterBio Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 RoosterBio Exosome Service Product Portfolio
- 6.12.5 RoosterBio Recent Developments
- 6.13 Clara Biotech
- 6.13.1 Clara Biotech Company Information
- 6.13.2 Clara Biotech Business Overview
- 6.13.3 Clara Biotech Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Clara Biotech Exosome Service Product Portfolio
- 6.13.5 Clara Biotech Recent Developments
- 6.14 Luminous BioSciences
- 6.14.1 Luminous BioSciences Company Information
- 6.14.2 Luminous BioSciences Business Overview
- 6.14.3 Luminous BioSciences Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Luminous BioSciences Exosome Service Product Portfolio
- 6.14.5 Luminous BioSciences Recent Developments
- 6.15 Capital Biosciences
- 6.15.1 Capital Biosciences Company Information
- 6.15.2 Capital Biosciences Business Overview
- 6.15.3 Capital Biosciences Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Capital Biosciences Exosome Service Product Portfolio
- 6.15.5 Capital Biosciences Recent Developments
- 6.16 Anazao
- 6.16.1 Anazao Company Information
- 6.16.2 Anazao Business Overview
- 6.16.3 Anazao Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Anazao Exosome Service Product Portfolio
- 6.16.5 Anazao Recent Developments
- 6.17 Alpha Nano Tech
- 6.17.1 Alpha Nano Tech Company Information
- 6.17.2 Alpha Nano Tech Business Overview
- 6.17.3 Alpha Nano Tech Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Alpha Nano Tech Exosome Service Product Portfolio
- 6.17.5 Alpha Nano Tech Recent Developments
- 6.18 NCELL
- 6.18.1 NCELL Company Information
- 6.18.2 NCELL Business Overview
- 6.18.3 NCELL Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 NCELL Exosome Service Product Portfolio
- 6.18.5 NCELL Recent Developments
- 6.19 Wayen Biotechnologies (Shanghai)
- 6.19.1 Wayen Biotechnologies (Shanghai) Company Information
- 6.19.2 Wayen Biotechnologies (Shanghai) Business Overview
- 6.19.3 Wayen Biotechnologies (Shanghai) Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 Wayen Biotechnologies (Shanghai) Exosome Service Product Portfolio
- 6.19.5 Wayen Biotechnologies (Shanghai) Recent Developments
- 6.20 Shanghai Yanjiang Biotechnology
- 6.20.1 Shanghai Yanjiang Biotechnology Company Information
- 6.20.2 Shanghai Yanjiang Biotechnology Business Overview
- 6.20.3 Shanghai Yanjiang Biotechnology Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.20.4 Shanghai Yanjiang Biotechnology Exosome Service Product Portfolio
- 6.20.5 Shanghai Yanjiang Biotechnology Recent Developments
7 North America
- 7.1 North America Exosome Service Market Size (2021-2032)
- 7.2 North America Exosome Service Market Size by Type
- 7.2.1 North America Exosome Service Market Size by Type (2021-2026)
- 7.2.2 North America Exosome Service Market Size by Type (2027-2032)
- 7.2.3 North America Exosome Service Market Share by Type (2021-2032)
- 7.3 North America Exosome Service Market Size by Application
- 7.3.1 North America Exosome Service Market Size by Application (2021-2026)
- 7.3.2 North America Exosome Service Market Size by Application (2027-2032)
- 7.3.3 North America Exosome Service Market Share by Application (2021-2032)
- 7.4 North America Exosome Service Market Size by Country
- 7.4.1 North America Exosome Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Exosome Service Market Size by Country (2021-2026)
- 7.4.3 North America Exosome Service Market Size by Country (2027-2032)
- 7.4.4 North America Exosome Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Exosome Service Market Size (2021-2032)
- 8.2 Europe Exosome Service Market Size by Type
- 8.2.1 Europe Exosome Service Market Size by Type (2021-2026)
- 8.2.2 Europe Exosome Service Market Size by Type (2027-2032)
- 8.2.3 Europe Exosome Service Market Share by Type (2021-2032)
- 8.3 Europe Exosome Service Market Size by Application
- 8.3.1 Europe Exosome Service Market Size by Application (2021-2026)
- 8.3.2 Europe Exosome Service Market Size by Application (2027-2032)
- 8.3.3 Europe Exosome Service Market Share by Application (2021-2032)
- 8.4 Europe Exosome Service Market Size by Country
- 8.4.1 Europe Exosome Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Exosome Service Market Size by Country (2021-2026)
- 8.4.3 Europe Exosome Service Market Size by Country (2027-2032)
- 8.4.4 Europe Exosome Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Exosome Service Market Size (2021-2032)
- 9.2 China Exosome Service Market Size by Type
- 9.2.1 China Exosome Service Market Size by Type (2021-2026)
- 9.2.2 China Exosome Service Market Size by Type (2027-2032)
- 9.2.3 China Exosome Service Market Share by Type (2021-2032)
- 9.3 China Exosome Service Market Size by Application
- 9.3.1 China Exosome Service Market Size by Application (2021-2026)
- 9.3.2 China Exosome Service Market Size by Application (2027-2032)
- 9.3.3 China Exosome Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Exosome Service Market Size (2021-2032)
- 10.2 Asia Exosome Service Market Size by Type
- 10.2.1 Asia Exosome Service Market Size by Type (2021-2026)
- 10.2.2 Asia Exosome Service Market Size by Type (2027-2032)
- 10.2.3 Asia Exosome Service Market Share by Type (2021-2032)
- 10.3 Asia Exosome Service Market Size by Application
- 10.3.1 Asia Exosome Service Market Size by Application (2021-2026)
- 10.3.2 Asia Exosome Service Market Size by Application (2027-2032)
- 10.3.3 Asia Exosome Service Market Share by Application (2021-2032)
- 10.4 Asia Exosome Service Market Size by Country
- 10.4.1 Asia Exosome Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Exosome Service Market Size by Country (2021-2026)
- 10.4.3 Asia Exosome Service Market Size by Country (2027-2032)
- 10.4.4 Asia Exosome Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Exosome Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Exosome Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Exosome Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Exosome Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Exosome Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Exosome Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Exosome Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Exosome Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Exosome Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Exosome Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Exosome Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Exosome Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Exosome Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Exosome Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst